Efavirenz is a non-nucleoside reverse transcriptase inhibitor medication used as part of HIV treatment protocols.
Efavirenz belongs to a class of medicines called non-nucleoside reverse-transcriptase inhibitors (NNRTIs). It works as part of antiretroviral therapy to help control infection with the human immunodeficiency virus (HIV). In Hong Kong, efavirenz is approved by the Pharmacy and Poisons Board and the Department of Health for use in adults living with HIV. It is found in products such as Sustiva and generic Efavirenz tablets.
Several formulations on the Hong Kong market include efavirenz as the active ingredient. The most common ones are:
Both are oral tablets designed for swallowing with water. In addition to single-ingredient products, efavirenz is also combined with other antiretrovirals in fixed-dose combinations that simplify treatment. The availability of specific brand names or combination pills may vary between pharmacies and hospitals in Hong Kong.
Efavirenz is used as part of a combination regimen to treat HIV infection. It is not given alone for cure, but it helps keep the virus at low levels when taken with other antiretroviral drugs. The main uses include:
While efavirenz is primarily approved for these indications, clinicians may sometimes select it for other situations based on individual health needs and current guidelines.
Efavirenz interferes with a key step in the HIV life cycle. After the virus enters a cell, it needs an enzyme called reverse transcriptase to turn its genetic material into a form the cell can read. Efavirenz blocks this enzyme, slowing down the production of new virus particles. Because the block is not permanent, the drug needs to be taken regularly to maintain its effect. Most people notice a drop in viral load within a few weeks of consistent use.
These effects are generally temporary and improve as the body adjusts to the medication.
If any of these occur, seek emergency medical help right away.
Efavirenz may affect how other medicines work. Notable interactions include:
Patients should review all current medications, herbal products, and supplements with a qualified health professional before starting efavirenz.
Store tablets at room temperature, away from excessive heat and moisture. Keep them out of reach of children. Treatment duration varies; some people use efavirenz for many years as part of a lifelong HIV regimen, while others may stop after switching to a different combination. Always follow the specific instructions that come with your medication, as formulations and strengths differ. For detailed dosing and administration, refer to the individual product’s information sheet.
Reverse transcriptase: An enzyme the HIV virus uses to copy its genetic material inside human cells.
Non-nucleoside reverse-transcriptase inhibitor (NNRTI): A group of drugs that block reverse transcriptase in a way that does not involve building blocks of DNA.
Viral load: The amount of HIV present in a blood sample, measured to gauge how well therapy is working.
This article offers general educational information about efavirenz as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing efavirenz may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow a qualified health professional’s guidance for complete information on proper use, dosage, and safety.
